A federal judge overseeing a lawsuit against the Justice Department said Friday that she remains skeptical the Trump administration’s $1.8 billion Anti-Weaponization Fund is fully dissolved, despite repeated assertions from DOJ officials that the program has been rescinded.
The U.S. District Court Judge Leonie Brinkema questioned whether the fund’s termination was absolute or if a functional equivalent exists through other DOJ mechanisms. Brinkema’s remarks came during a hearing where DOJ lawyers argued that Attorney General Todd Blanche had formally rescinded the fund in August and testified under oath before Congress that it was dead.
Brinkema countered that the Judgment Fund—a permanent Treasury account used to pay court judgments and settlements—could serve as a less transparent alternative for compensating politically aligned defendants. She cited the case of Paul Vaughn, a Tennessee man convicted in 2024 for blockading an abortion clinic, who received a pardon and a taxpayer-funded payout from the Judgment Fund.
DOJ’s Position
DOJ lawyers maintain the Anti-Weaponization Fund is permanently defunct, pointing to Blanche’s formal rescission order and his congressional testimony. They argue the fund was a one-time initiative and that no equivalent mechanism exists. The DOJ has not provided further details on how the Judgment Fund’s use in such cases aligns with its stated policies.
Judge’s Concerns
Brinkema’s skepticism centers on two key issues:
- Transparency: She described the Judgment Fund as a less transparent structure compared to the now-defunct Anti-Weaponization Fund, raising concerns about public oversight.
- Political Compensation: The judge questioned whether taxpayer money could be used to compensate allies of the Trump administration prosecuted under the Biden administration, citing Vaughn’s case as an example.
Background Context
The Anti-Weaponization Fund was established under the Trump administration with a budget of $1.776 billion, purportedly to address alleged political weaponization of federal agencies. Critics argued it could be used to reimburse legal fees for individuals prosecuted for actions like the January 6 Capitol breach or violations of the FACE Act, which prohibits interference with reproductive healthcare access.
The fund’s rescission followed legal challenges and political backlash, but Brinkema’s remarks suggest the underlying issues—particularly regarding judicial discretion and fiscal accountability—remain unresolved. The case is ongoing, with no immediate ruling issued.